BASF PHARMA BELGIUM
0845.445.466 · rovalta.com · 24/09/2026
ACTIVE
BASF PHARMA BELGIUM
Financial year 2025 · closed on 31/12/2025
Net result
183,2 k €
-45.6% YoY
Equity
11,6 M €
+1.6% YoY
Overview
What does BASF PHARMA BELGIUM do?
BASF PHARMA BELGIUM is a Public limited company incorporated in 2012. Its registered office is in Antwerpen.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0845.445.466
Incorporation
23/04/2012
Legal form
Public limited company
Registered office
Scheldelaan 600
2040 Antwerpen · FlandreSee on map
2040 Antwerpen · FlandreSee on map
Contributed capital
48 000 000,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflow
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||
| EBITDA | -68,6 k € | +9.1% | -75,4 k € | -39.6% | -54 k € | -7.3% | -50,4 k € | -76.5% | -28,5 k € | -6.0% | -26,9 k € | +6.1% | -28,6 k € | +2.3% | -29,3 k € | +58.0% | -69,7 k € | -88.1% | -37,1 k € | +4.8% | -38,9 k € | -7.3% | -36,3 k € | -2.2% | -35,5 k € | +93.5% | -547,9 k € |
| Operating result | -68,6 k € | +9.1% | -75,4 k € | -39.6% | -54 k € | -7.3% | -50,4 k € | -76.5% | -28,5 k € | -6.0% | -26,9 k € | +6.1% | -28,6 k € | +2.3% | -29,3 k € | +58.0% | -69,7 k € | -88.1% | -37,1 k € | +4.8% | -38,9 k € | -7.3% | -36,3 k € | -2.2% | -35,5 k € | +93.5% | -547,9 k € |
| Net result | 183,2 k € | -45.6% | 337,1 k € | +13.7% | 296,4 k € | +1813% | -17,3 k € | +39.4% | -28,5 k € | -6.0% | -26,9 k € | +6.1% | -28,6 k € | +99.9% | -35 M € | -49640% | -70,4 k € | -85.9% | -37,9 k € | +93.4% | -570,6 k € | -44.4% | -395,2 k € | +33.2% | -592 k € | -44.4% | -410,1 k € |
| Balance sheet | |||||||||||||||||||||||||||
| Equity | 11,6 M € | +1.6% | 11,4 M € | +3.0% | 11,1 M € | +2.7% | 10,8 M € | -0.2% | 10,8 M € | -0.3% | 10,9 M € | -0.2% | 10,9 M € | -0.3% | 10,9 M € | -76.2% | 45,9 M € | -0.2% | 46 M € | -0.1% | 46 M € | -1.2% | 46,6 M € | -0.8% | 47 M € | -1.2% | 47,6 M € |
| Total assets | 11,6 M € | +1.6% | 11,5 M € | +3.2% | 11,1 M € | +2.8% | 10,8 M € | -0.2% | 10,8 M € | -0.2% | 10,9 M € | -0.3% | 10,9 M € | -0.3% | 10,9 M € | -76.2% | 45,9 M € | -0.1% | 46 M € | -0.1% | 46 M € | -13.2% | 53 M € | -0.6% | 53,3 M € | -17.5% | 64,7 M € |
| Debts | 19,2 k € | -20.4% | 24,1 k € | +153% | 9,5 k € | +22.5% | 7,8 k € | -5.7% | 8,2 k € | +74.0% | 4,7 k € | -10.2% | 5,3 k € | +24.1% | 4,3 k € | -80.1% | 21,4 k € | +234% | 6,4 k € | +57.8% | 4 k € | -99.9% | 6,4 M € | +7.0% | 6 M € | -64.9% | 17,1 M € |
Estimate
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 3 active · 14 ended
Active mandates
Bart Goossens
ActiveJan Remeysen
ActiveStefanie Demming
ActiveEnded mandates
Stefanie Demming
EndedJan Remeysen
EndedThorsten Oberreuther
EndedThorsten Oberreuther
EndedAt this address
Other companies at this address
| Company | CBE no. |
|---|---|
BASF Antwerpen● Active | 0404.754.472 |
BASF BELGIUM COORDINATION CENTER● Active | 0862.390.376 |
BASF DOW HPPO PRODUCTION● Active | 0879.406.156 |
BASF Kaderleden en Directie● Active | 0448.501.769 |
BASF Personeelsclub● Active | 0419.018.620 |
BASF VOORZORGSFONDS● Active | 0448.496.920 |
| 0448.496.821 | |
EuroChem Antwerpen● Active | 0837.473.452 |
EUROCHEM ANTWERPEN● Active | 0842.037.204 |
INEOS STYROLUTION BELGIUM● Active | 0806.439.291 |
ZANDVLIET POWER● Active | 0477.543.470 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/05/2026 | 05/05/2025 | 13/05/2024 | 04/05/2023 | 02/06/2022 | 26/04/2021 |
| General meeting | 23/04/2026 | 17/04/2025 | 18/04/2024 | 20/04/2023 | 21/04/2022 | 22/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
14 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 23/04/2026 | 28/05/2026 | Dutch | |
| Full model | 31/12/2024 | 17/04/2025 | 05/05/2025 | Dutch | |
| Full model | 31/12/2023 | 18/04/2024 | 13/05/2024 | Dutch | |
| Full model | 31/12/2022 | 20/04/2023 | 04/05/2023 | Dutch | |
| Full model | 31/12/2021 | 21/04/2022 | 02/06/2022 | Dutch | |
| Full model | 31/12/2020 | 22/04/2021 | 26/04/2021 | Dutch | |
| Full model | 31/12/2019 | 23/04/2020 | 13/10/2020 | Dutch | |
| Full model | 31/12/2018 | 18/04/2019 | 17/05/2019 | Dutch | |
| Full model | 31/12/2017 | 19/04/2018 | 16/05/2018 | Dutch | |
| Full model | 31/12/2016 | 20/04/2017 | 30/05/2017 | Dutch | |
| Full model | 31/12/2015 | 21/04/2016 | 19/05/2016 | Dutch | |
| Full model | 31/12/2014 | 23/04/2015 | 01/06/2015 | Dutch | |
| Full model | 31/12/2013 | 17/04/2014 | 15/05/2014 | Dutch | |
| Full model | 31/12/2012 | 18/04/2013 | 17/05/2013 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 3 active · 14 ended
Active mandates
Bart Goossens
ActiveJan Remeysen
ActiveStefanie Demming
ActiveEnded mandates
Stefanie Demming
EndedJan Remeysen
EndedThorsten Oberreuther
EndedThorsten Oberreuther
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates09/06/2026ONTSLAGEN - BENOEMINGEN
- Mandates02/02/2026ONTSLAGEN - BENOEMINGEN
- Mandates19/05/2025ONTSLAGEN - BENOEMINGEN
- Mandates24/02/2025ONTSLAGEN - BENOEMINGEN
- Mandates12/06/2024ONTSLAGEN - BENOEMINGEN
- Other11/05/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates20/05/2022ONTSLAGEN - BENOEMINGEN
- Mandates03/08/2021ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 01/01/2026nominationBart Goossens — bestuurder
- 2025Annual accounts 2025183,2 k €↓
- 08/12/2025nominationBart Goossens — bestuurder
- 2024Annual accounts 2024337,1 k €↑
- 01/12/2024nominationStefanie Demming — bestuurder
- 18/04/2024nominationDeloitte Bedrijfsrevisoren BV — commissaris
- 2023Annual accounts 2023296,4 k €↑
- 2022Annual accounts 2022-17,3 k €↑
- 21/04/2022reconductionJan Remeysen — bestuurder
- 21/04/2022reconductionThorsten Oberreuther — bestuurder
- 2021Annual accounts 2021-28,5 k €↓
- 2020Annual accounts 2020-26,9 k €↑
- 2019Annual accounts 2019-28,6 k €↑
- 2018Annual accounts 2018-35 M €↓
- 2017Annual accounts 2017-70,4 k €↓
- 2016Annual accounts 2016-37,9 k €↑
- 2015Annual accounts 2015-570,6 k €↓
- 2014Annual accounts 2014-395,2 k €↑
- 2013Annual accounts 2013-592 k €↓
- 2012Annual accounts 2012-410,1 k €
- 23/04/2012IncorporationPublic limited company